ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bearish•Siam Cement
•05 Jan 2023 10:56•Broker

Market Outlook

The SET Index is expected to move sideways, with the resistance at 1,684/1,690 points and the support at 1,664/1,655 points. Downward pressure...

Logo
89 Views
Share
•21 Nov 2022 10:49•Broker

Market Outlook and Technical Analysis

The SET Index is expected to move up, with the resistance at 1,630/1,635 points and the support at 1,611/1,600 points. We recommend trading buy on...

Logo
89 Views
Share
•09 Nov 2022 10:43•Broker

Market Outlook

The SET Index is expected to move sideways up, with the resistance at 1,636/1,649 points and the support at 1,612 points (200-day EMA)/1,607...

Logo
88 Views
Share
bullish•PSL
•08 Nov 2022 11:00•Broker

Market Outlook

The SET Index is expected to move sideways, with the resistance at 1,631/1,649 points and the support at 1,612 points (200-day EMA)/1,607 points...

Logo
96 Views
Share
bullish•SCB X
•18 Oct 2022 10:39•Broker

Recommendation: Buy on Weakness, Sell on Strength

The SET Index is expected to increase, with the resistance at 1,578/1,585 points and the support at 1,560/1,550 points. Technically, there is a...

Logo
94 Views
Share
x